# Corneal Thinning During Topical Bevacizumab Therapy

> **NCT00515684** · NA · WITHDRAWN · sponsor: **Yonsei University**

## Conditions studied

- Corneal Neovascularization

## Interventions

- **DRUG:** bevacizumab (Avastin)

## Key facts

- **NCT ID:** NCT00515684
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-05
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Side effect can increase the risk of the research
- **Last updated:** 2015-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515684, "Corneal Thinning During Topical Bevacizumab Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00515684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*